Clinical experience with a lipid‐free, ready‐made parenteral nutrition solution in dogs: 70 cases (2006–2012)

Abstract

This form of PN is suitable for clinical use and can provide both protein and calories to ill dogs. It was, however, associated with a high rate of complications and requires careful patient monitoring.

Retrospective evaluation of ProcalAmine administration in a population of hospitalized ICU dogs: 36 cases (2010–2013)

“…The degree and onset of damage is determined by a solution's osmolarity. While the notable differences in acidity and osmolarity of ProcalAmine compared to Vamin 9 might suggest that phlebitis would be more commonly observed following administration of the latter, this was not the case when comparing our study to that by Gajanayake et al…”

“…In the current study, there was an overall mechanical complication rate of 19%, compared to a 40% mechanical complication rate reported in a recent study by Gajanayake et al that evaluated a similar lipid‐free ready‐made PN solution, Vamin 9 . In both studies, mechanical complications occurred more commonly following peripheral administration of PN.…”

“…In their study, 63% of hyperkalemic dogs were receiving additional potassium supplementation. The observed hyperkalemia in these dogs was mild, and no clinical signs referable to this electrolyte abnormality were reported . Vamin 9 and ProcalAmine contain 20 mEq/L and 25 mEq/L of potassium, respectively.…”

“…In the current study, there was an overall mechanical complication rate of 19%, compared to a 40% mechanical complication rate reported in a recent study by Gajanayake et al that evaluated a similar lipid-free ready-made PN solution, Vamin 9. 19 In both studies, mechanical complications occurred more commonly following peripheral administration of PN. In contrast to the aforementioned study, which reported catheter dislodgement as the most common mechanical complication, phlebitis accounted for the majority of mechanical complications in the current study.…”

“…This differs from previous reviews of PN in small animals that documented pancreatitis as the most common primary disease process. [17][18][19] The urban location of this hospital may, in part, account for this difference in patient cohorts. Additionally, the preferential use of EN over PN in most pancreatitic patients in recent years may help explain the change in patients selected for PN administration.…”